Related Experiment Video
Updated: Oct 1, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy
Sarah M Schneider1, Garett T Sansom2, Lee-Jae Guo3
1Department of Veterinary Pathobiology, Texas A&M University, College Station, TX, United States.
Insights
Golden Retriever muscular dystrophy (GRMD) dogs show cardiac lesions similar to Duchenne muscular dystrophy (DMD) in humans. This study systematically assessed GRMD dog hearts, validating GRMD as a model for studying cardiomyopathy and potential treatments.
Area of Science:
- Cardiovascular Pathology
- Comparative Pathology
- Animal Models of Human Disease
Background:
- Duchenne muscular dystrophy (DMD) causes progressive muscle disease, with cardiomyopathy being the leading cause of death.
- Cardiomyopathy diagnostics and treatment in DMD lag behind skeletal muscle disease management.
- Golden Retriever muscular dystrophy (GRMD) dogs exhibit progressive cardiomyopathy analogous to DMD, unlike the milder form in mdx mice.
Purpose of the Study:
- To systematically assess cardiac lesions in GRMD dogs and carriers.
- To validate the GRMD model for studying cardiomyopathy pathogenesis and treatment.
- To investigate potential contributing factors to disease progression in GRMD cardiomyopathy.
Main Methods:
- Systematic assessment of cardiac lesions in 31 GRMD and carrier dogs (3-76 months) and normal hounds.
- Semi-quantitative lesion scoring and quantitation of fibrosis cross-sectional area.
- Correlation of histopathologic changes with cardiac MRI findings (late gadolinium enhancement).
Main Results:
- Lesion scoring and fibrosis quantitation distinguished GRMD dogs from normal hounds.
- GRMD carriers showed intermediate involvement with significant fibrosis.
- Fatty infiltration, vascular hypertrophy, and Purkinje fiber vacuolation were observed in GRMD dogs, correlating with lesion severity and MRI findings.
Conclusions:
- Cardiac lesions in GRMD dogs are compatible with DMD, validating GRMD as a model for cardiomyopathy research.
- The findings suggest GRMD is a suitable model for studying cardiomyopathy pathogenesis and treatment strategies.
- Functional hypoxia or non-thrombotic ischemia may play a role in the progression of GRMD cardiomyopathy.
Background:
Duchenne muscular dystrophy (DMD) is an X-linked inherited myopathy that causes progressive skeletal and cardiac muscle disease. Heart lesions were described in the earliest DMD reports, and cardiomyopathy is now the leading cause of death. However, diagnostics and treatment for cardiomyopathy have lagged behind those for appendicular and respiratory skeletal muscle disease. Most animal model studies have been done in the mdx mouse, which has a relatively mild form of cardiomyopathy. Dogs with the genetically homologous condition, Golden Retriever muscular dystrophy (GRMD), develop progressive cardiomyopathy analogous to that seen in DMD. Previous descriptive studies of GRMD cardiomyopathy have mostly been limited to selective sampling of the hearts from young dogs.
Methods And Results:
We systematically assessed cardiac lesions in 31 GRMD and carrier dogs aged 3 to 76 months and a separate cohort of 2-10-year-old normal hounds. Both semi-quantitative lesion scoring and quantitation of the cross-sectional area of fibrosis distinguished dogs with GRMD disease from normal dogs. The carriers generally had intermediate involvement but had even greater fibrosis than GRMD dogs. Fatty infiltration was the most prominent feature in some older GRMD dogs. Vascular hypertrophy was increased in GRMD dogs and correlated positively with lesion severity. Purkinje fiber vacuolation was also increased but did not correlate with lesion severity. Histopathologic changes correlated with late gadolinium enhancement on cardiac MRI.
Conclusion:
These features are generally compatible with those of DMD and further validate GRMD as a useful model to study cardiomyopathy pathogenesis and treatment. Additionally, the nature of some degenerative lesions suggests that functional hypoxia or non-thrombotic ischemia may contribute to disease progression.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy

